Infectious Disease Regulation

Original Language Title: Tartuntatautiasetus

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now

Read the untranslated law here: http://www.finlex.fi/fi/laki/ajantasa/1986/19860786

Presentation by the Minister of Social Affairs and health, 25 July 1986 laying down detailed rules for the infectious disease Act (583/86), section 7 (2), section 10 (3), section 20, subsection 1, 33 and 41 pursuant to section: section 1 section 1 of the (30.12.2003/1383) has been revoked A 30.12.2003/1383.


section 2 of the Yleisvaarallisia (23.7.2009/556) infectious diseases are: ehec infection hepatitis A influenza A virus subtype H5N1 smallpox yellow fever cholera syphilis diphtheria typhoid fever, paratyphoid fever and other diseases caused by meningococcal septiset disease caused by 9B and meningeal inflammation anthrax polio, the plague of sars shigellapunatauti tuberculosis and viral haemorrhagic fevers, not Mole fever.
Infectious diseases are nihil: botulism, a new variant of Creutzfeldt-Jakob disease septiset disease caused by echinococcosis, hemofiluksen and meningeal inflammation in hepatitis B hepatitis (C) whooping cough are spreading hiv infection sexually transmitted chlamydia infections, tuberculosis, malaria, other mykobakteeritaudit legionelloosi of listeriosis as tick-borne encephalitis rabies sankkerit mumps gonorrhea, measles and rubella.


section 3 (30.12.2003/1383) the Ministry of Social Affairs and health will be a communicable disease for the purposes of the Act (583/1986) tasks, in addition to that prescribed by law: 1) take care of the necessary work for the population of the infectious disease control, as well as information on the implementation of the health education by the national grid;
2) to monitor and promote the country-side and international communicable disease control work-related scientific research and its application; as well as 3) to run the Ministry of Social Affairs and health to prevent infectious diseases specified other tasks.


section 4 (December 29/1838) the regional government for the purposes of the law, the tasks of the Agency will be a communicable disease, in addition to that prescribed by law: 1) the situation in the territory to monitor infectious disease;
2) to plan and direct the work of the Office in its territory, as well as infectious disease control to ensure that the rules and regulations are complied with;
3) to make, where necessary, the Ministry of Social Affairs and health performances of the measures for the prevention of communicable diseases;
4) will carry out a regional government agency for the prevention of communicable diseases in the specified or other tasks.


section 5 (30.12.2003/1383), the tasks of the infectious disease Hospital for the purposes of the Act will be in addition to the prescribed by law: 1) to ensure that the hospital is available for the necessary treatment of communicable diseases, specialist care services;
2) arrange for the necessary training for the job of opposition sairaanhoitopiirissä of communicable diseases;
3 the development of infectious disease control) to participate in the work of the hospital.
4) provide the health centre on communicable diseases, taking into account the corresponding to the doctor, section 10 (3) of the restrictions on the disclosure of a summary of the information on the infectious disease notifications, which is registered in the territory of the health centre; as well as 5 regional information related to communicable diseases) to take care of health-care professionals.


section 6 (30.12.2003/1383) corresponding to the control of communicable diseases in the work under the municipal institutions and the health center of infectious diseases physician should contribute to responsible for communicable disease for the purposes of tasks that, in addition to the law as provided by law: 1) take care of the health center's work in the area of infectious disease control work, which includes information on communicable diseases, health education and health advice, including intravenous drug users in the fight against communicable diseases, health advice and the use of instruments required to change as necessary;
2) to ensure that the yleisvaaralliseen of infectious disease or a person suspected of being infected will be examined;
3 if necessary, to arrange for the treatment yleisvaaralliseen) to take the measures of infectious disease sick days;
4) take any other appropriate measures provided for in the yleisvaarallisen of a communicable disease, or separately; in order to prevent infectious diseases, as well as 5) perform other tasks provided for in, or separately.


section 7 (30.12.2003/1383), the National Institute for health and welfare: (December 29/1838) 1 point has been repealed A 21 December 2006/1376.


(2) repealed A 21 December 2006/1376.


(3) repealed A 21 December 2006/1376.

4 the implementation of communicable disease control) to monitor the work of the Ministry of Social Affairs and health, and to make proposals on measures to prevent infectious diseases;
5) carries out scientific research related to communicable diseases and to carry out and develop the infectious disease control in the laboratory studies;
6) take care of infectious diseases for the national information on;
7) give the work of the institutions responsible for the fight against communicable diseases and outbreaks of communicable diseases sairaanhoitopiireille expert advice on deciphering the;
8) to organize the work of the education and training in infectious disease control;
the current situation of communicable disease, 9) sairaanhoitopiireille, laboratories and health centres, as well as providing information about the Ministry of Social Affairs and health, the regional government agencies, armed forces, border guards and the international exchange of information on communicable diseases; (December 29, 2009/1838) 10) to participate in the work of the national infectious disease control and international cooperation; as well as 11) perform other prescribed or the Ministry of Social Affairs and health in the work related to the tasks of the opposition määräämättartuntatautien.


section 8 section 8 (30.12.2003/1383) has been revoked A 30.12.2003/1383.


section 9 (30 December 2008/1125) Vaccine by injection may be given only by your doctor, as well as the appropriate training received from other health care professional under the supervision of a doctor.


section 10 (30.12.2003/1383) the doctor or dentist has to make a declaration, hereinafter referred to as the infectious disease-medical infectious disease notification, with the exception of the communicable diseases to be notified yleisvaarallisista and whooping cough, typhoid fever or other salmonellosis as pikkulavantautia, puutiaisaivokuumetta, hemofiluksen and septisiä diseases caused by meningeal infection, sexually transmitted infections spreading chlamydia infections, tuberculosis, as well as other mykobakteeritauteja as the new variant of Creutzfeldt-Jakob disease. The dentist can, however, control infectious diseases patients with the diagnosis a doctor, the doctor will do a communicable disease, in the statement. Medical infectious disease notification contains a communicable disease for the purposes of article 23 of the law, in addition to the information in the data tag information of the patient's gender, nationality, asuinkunnasta and treatment of the place, the starting point of the symptoms of the infection, and the criteria for diagnosis. In addition, the notifier shall mark the statement with the signature and contact information. (21 December 2006/1376)
Medical infectious disease notification must be made within seven days of the case. In a case of special urgency as the doctor's preliminary information must be made immediately by telephone at the health centre and hospital of infectious diseases for the doctor and the health and well-being of the body. The phone was a preliminary notification shall be written by means of a communicable disease, in the case. Notification of tuberculosis is to be done, as well as, when the infection has been found that, when the treatment is finished. (December 29, 2009/1838)
HIV infection makes infectious disease notification at the time of detection of infection, disease and the death of the patient upon arrival at the AIDS stage. HIV-infection to the task notification is included in the assessment of the infectious disease doctor-infection-the time and the way, the cause of death and whether the infected donated blood. The National Institute for health and welfare may disclose information about hiv-infection at the health centre on communicable diseases for the doctor, only without the person's credentials. (30 December 2008/1115), section 10 (a) (30.12.2003/1383) shall be carried out by a laboratory for infectious diseases-notice of yleisvaarallisen and identification of the pathogen of infection being notified, as well as other subject to microbial discovery. Other registered microbial findings are listed in annex 1.
Regional drug-resistant strains of microbes to the applicants in the register shall be deposited in the highly infectious disease provided for in article 23 of the law, and article 23 (a) and (b) of this regulation, and the information referred to in article 10 the following microbial applicants: 1) Escherichia coli or Klebsiella pneumoniae with reduced sensitivity (III) generation cephalosporins (that);
2) Methicillin/penicillin resistant Staphylococcus aureus (MRSA);
Vancomycin resistant enterococci 3) (VRE); and 4) Vancomycin Resistant staphylococci.
(30 December 2008/1115), section 10 (b) (30.12.2003/1383)


Laboratory of infectious disease notification includes infectious disease within the meaning of article 23 of the law, in addition to the information in the data tag information on the treatment of the place, the date of identification of sampling for the study, on the quality of the sample, as well as the detection method of the microorganism, the name of the reporting laboratory. If the sample is sent to a lab other than ilmoittavasta or sent for further tests in another laboratory, including their names, must be reported. Salmonella, shigella and Campylobacter infections shall inform the infection. All of the laboratory of infectious diseases-the name of the laboratory must also inform the notices. When the laboratory finding in the case of a communicable disease, which refers to the attending physician is required to make a notification of communicable diseases, the laboratory must be accompanied by their own response to this note.
The laboratory of infectious diseases-the notification shall be made not later than three days after finding the confirmation.


10 (c) of section (21 December 2006/1376), notification of infectious diseases-all information is kept the same in the case of a communicable disease, in the end of the mail merge to merge the separate declarations, hereinafter referred to as the time interval until the end of the following year. After this, the data is removed from the patient's name and ID code is changed to a format where it can not be identified.
The merge interval is 50 years, in the case of typhoid fever, paratyphoid fever, syphilis, tuberculosis, hepatitis B, hepatitis C, hiv-infection, other mykobakteeritauti like tuberculosis, hepatitis D virus-induced disease, HTL-caused by a virus of the disease, new variant Creutzfeldt-Jakob disease, or methicillin, penicillin-resistant Staphylococcus aureus (MRSA) or vancomycin resistant stafylokokkikannan (VRSA), vancomycin resistant enterokokin (VRE) or (III) the generation of cephalosporins with reduced sensitivity of Escherichia coli or Klebsiella pneumoniae strain caused by infection with the exception of the septisiä infections and meningeal inflammation. (13 December 2007/1238)
The merge interval is three years, in the case of echinococcosis, malaria, Borrelia burgdorferi, Brucella, blood or spinal fluid fungal or parasitic filaria and finding, skistosoma.
The merge interval is three months, in the case of meningitis caused by septic disease or meningitis, gonorrhea, clostridium difficilen, hemofiluksen, MRSA:n, VRSA:n, VRE:n, or (III) the generation of cephalosporins with reduced sensitivity of Escherichia coli or Klebsiella pneumoniae-induced septic disease and brain membrane infection, sexually transmitted infections chlamydia, chancroid, spread across the rest of the blood and cerebrospinal fluid finding in bacterial or viral or astroviruksen, the flu virus, fluenssaviruksen, kalikiviruksen parain-(including noro virus), respiratory syncytial virus , rinoviruksen and rotavirus-induced disease. (13 December 2007/1238)
In all other infectious diseases in the merge interval is 12 months.


section 11 (30.12.2003/1383) an employer is required under section 20 of the laws of the infectious disease in the tasks referred to in the statement of the competence of the employee that the employee is suffering from salmonellosis or respiratory tuberculosis. A statement by you, that an employee suffering from salmonellosis, is also required from a person who is employed in the processing of the milk in the milk on the farm, the milk goes into the tasks for consumption without the pasteurization process.


section 12 (30.12.2003/1383) infectious disease pursuant to article 23 of the law, in accordance with paragraph 2 of the notice shall be accompanied by the infectious disease laboratories-microbial strains or samples in accordance with Annex 2.


section 13 (30 December 2008/1107) 23 (c) of the laws of the Infectious Disease section of the veterinary authority referred to in the reporting of communicable diseases are: 1) the rabies (rabies) and suspicion;
2) of anthrax and suspicion;
a volume of 3);
4) Mycobacterium bovis infection;
Burkholderia mallei (Pseudomonas) 5);
6) psittacosis.
7) ehec infection in a person who has been in contact with farm animals in the home country;
8) salmonella infection, Q fever or leptospirosis, a person who resides or works in the production of animal farm;
9) trichinellosis;
10) botulism and suspicion.


section 14 if the infectious disease law of the institution referred to in article 9, the State removed the person is because of yleisvaarallisen because of the infectious disease in need of treatment or to be notified, at the expense of the institution of the State is the proper treatment for him to forward to the place.


15-17 section 15 section 17 is repealed A 30.12.2003/1383.




section 18 of This Regulation shall enter into force on 1 January 1987.
Before the entry into force of this regulation for the implementation of the necessary measures can be taken.


Annex 1, section 10 of the regulation on communicable diseases referred to in other non-microbial findings all the microbes, which have been found in the blood or spinal fluid, and in addition to these: Bacteria: Bordetella pertussis Borrelia burgdorferi Borrelia recurrentis Brusellat Chlamydia pneumoniae Chlamydia psittacii Clostridium difficile Coxiella burnetii, Enterobacter cloacae (positions of a sensitivity to carbapenems is impaired or who are resistant to carbapenems) Enterococci (VRE vancomycin resistant strains) Escherichia coli (positions, with the sensitivity of the III generation cephalosporins decreased) Escherichia coli (the positions of the with a sensitivity to carbapenems is impaired or who are resistant to carbapenems) isolation of Francisella tularensis Kampylobakteerit Klebsiella pneumoniae (positions, with the sensitivity of the III generation cephalosporins decreased), Klebsiella pneumoniae (positions of a sensitivity to carbapenems is impaired or who are resistant to carbapenems) Leptospirat Mycoplasma pneumoniae Staphylococcus aureus (Methicillin/penicillin resistant strains of MRSA) Staphylococci (vancomycin resistant strains, VRSA) Vibrio parahaemolyticus and Yersiniat.
Viruses: Adenoviruses Astrovirukset Coxsackievirukset Denguevirukset Echovirukset enteroviruses, including poliomyelitis virus Hepatitis (D) and (E)-HTL viruses influenza viruses of Japanese B encephalitis virus Kalikivirus (including noro virus) Parainfluenssavirukset Parvovirus Puumalavirus (Vole fever virus) Puutiaisenkefaliittivirus Respiratory syncytial virus Rinovirus Rotaviruses Sindbisvirus and the Varicella-zoster virus.
Cyclospora cayetanensis of Entamoeba histolytica/Filariat: Cryptosporidium Giardia lamblia Leishmaniat Skistosomat Toxoplasma gondii and Trichinella spiralis.
Pneumocystis carinii fungus:.


Annex 2 infectious disease pursuant to article 23 of the law, in accordance with the laboratories of a communicable disease, in the Declaration to be accompanied by a microbial strains or samples, follow these steps.
Yleisvaarallisia infectious diseases cause: Escherichia coli EHEC strain or a sample of hepatitis A a sample of Corynebacterium diphtheriae produces a toxin sample for Vibrio cholerae position or the position or the position or the sample Salmonellat sample of Neisseria meningitidis: blood and cerebrospinal fluid of the findings made in the Polio virus strain or a sample of the Shigellat database, or a sample of the Mycobacterium tuberculosis strain, or sample The infectious diseases: HIV or regarding the position of the sample or a sample of the Listeria monocytogenes strain or a sample of the Plasmodium sample Haemophilus influenzae strain : the blood and the cerebrospinal fluid of the findings made in the Mumps virus sample of the measles virus in a sample of the rubella virus sample of the Other registered microbial findings: the bacteria Enterobacter cloacae strain of Bordetella pertussis or samples (positions of a sensitivity to carbapenems is impaired or who are resistant to carbapenems) position: any position of the Enterococci (VRE) from the sample or a sample of the Escherichia coli (the positions of a sensitivity to carbapenems is impaired or who are resistant to carbapenems) position: any sample Klebsiella pneumoniae (the positions of the with a sensitivity to carbapenems is impaired or who are resistant to carbapenems) position: any position of the Staphylococcus aureus (MRSA) in the sample or a sample of the Stafylokokokit (vancomycin resistant strains), Streptococcus agalactiae, or sample database: the blood and the cerebrospinal fluid findings made in Streptococcus pneumoniae: the blood and the cerebrospinal fluid findings made in Streptococcus pyogenes strain: the blood and the cerebrospinal fluid findings made to the enteroviruses, including poliomyelitis Viruses (coxsackie and enteroviruses, including poliomyelitis) or sample: a sample of the findings made in the Rotavirus in the stool or change in the application of the date of entry into force of the acts and : 22.2.1991/407: This Regulation shall enter into force on 1 March 1991.




28.8.1992/833: This Regulation shall enter into force on 1 September 1992.
Before the entry into force of this Regulation may be to take the measures needed to implement it.
Social Affairs and Health issued by the Government prior to the entry into force of this regulation, entry of the infectious disease Act and the implementation of the provisions of the regulation or guidelines shall apply after the entry into force of this regulation until 1 January 1994, subject to the Ministry of Social Affairs and health, rather than let them new instructions or otherwise.




9.10.1992/913:


This Regulation shall enter into force on 1 January 1993.




17.12.1993/12: This Regulation shall enter into force on 1 January 1994.




furnished until 29 August 1997/841: This Regulation shall enter into force on 1 January 1998.




19.3.1999/357: This Regulation shall enter into force on 1 April 1999.




on April 24, 2003/322: This Regulation shall enter into force on 25 April 2003.




30.12.2003/1383: This Regulation shall enter into force on 1 January 2004.
Before the entry into force of this regulation for the implementation of the necessary measures can be taken.




on 21 December 2006/1376: This Regulation shall enter into force on 1 January 2007.




on 13 December 2007/1238: This Regulation shall enter into force on 1 January 2008.




30 December 2008/11: This Regulation shall enter into force on 1 January 2009.
Before the entry into force of this Regulation may be to take the measures needed to implement the regulation.




on 29 April 2009,/281: This Regulation shall enter into force on 1 may, 2009.
Before the entry into force of the regulation may be to take the measures needed to implement the regulation.




June 2009/389: This Regulation shall enter into force on 5 June 2009.
Before the entry into force of the regulation may be to take the measures needed to implement the regulation.




23.7.2009/556: This Regulation shall enter into force on 27 July 2009.




24.9.2009/707: This Regulation shall enter into force on 25 September, 2009 and shall remain in force until 31 May 2010.
Before the entry into force of this Regulation may be to take the measures needed to implement the regulation.




December 29, 2009/1838: This Regulation shall enter into force on 1 January 2010.
Before the entry into force of the regulation may be to take the measures needed to implement the regulation.




May 2010/369: This Regulation shall enter into force on 1 June 2010 and shall remain in force until 31 May 2011.
Before the entry into force of the regulation may be to take the measures needed to implement the regulation.




2.12.2010/1059: This Regulation shall enter into force on 1 January 2011.
Before the entry into force of the regulation may be to take the necessary steps in the implementation of the regulation.




18.4.2013/296: This Regulation shall enter into force on 1 may 2013.
Before the entry into force of the regulation may be to take the necessary steps in the implementation of the regulation.